US FDA’s ‘Active Moiety’ Approach On NCE Exclusivity Codified Under Drug Pricing Legislation

 
• By Sue Sutter
  
old door opens to space station
Legislative language on 'successor regulations' provides an opening to future changes in the FDA's definition of 'active moiety.'
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Legislation

More from Pink Sheet